Boston Family Office’s Corteva CTVA Stock Holding History

Boston Family Office’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,263	Closed	-$363K	–	254
2019 Q2	$363K	Buy	+12,263	New	+$330K	0.04%	220

Other funds holding CTVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Family Office's CTVA Position: Q3 2019 in Review

Boston Family Office sold out of Corteva (CTVA) in Q3 2019, closing a stake of 12,263 shares — an estimated $363K sold.

Boston Family Office first reported a position in CTVA in Q2 2019 and held it in 1 quarter. The position peaked at $363K in Q2 2019. 983 funds tracked by Wall St. Rank hold CTVA as of Q3 2019.

Boston Family Office reported no remaining Corteva position as of Q3 2019 after selling out during the quarter.
Boston Family Office sold 12,263 Corteva shares in Q3 2019, an estimated $363K.
Boston Family Office first reported a position in Corteva in Q2 2019 and held it in 1 quarter.
Boston Family Office's Corteva position peaked at $363K in Q2 2019.
983 funds tracked by Wall St. Rank held Corteva as of Q3 2019.

Based on Boston Family Office's 13F filing for Q3 2019, filed 12 Nov 2019.